极短宫颈(≤10 mm)且无自发性早产史的单胎妊娠行宫颈环扎术的疗效
本多中心回顾性队列研究纳入90例妊娠16–23周、宫颈长度≤10 mm且无自发性早产史的无症状单胎妊娠患者,比较宫颈环扎术与非环扎术的结局。环扎组至分娩时间间隔更长(17.0 vs 15.0周,P=.02),校正后早产风险更低(aHR 0.61,95%CI 0.38–0.99,P=.04),晚期早产更少(11.5% vs 31.6%,P=.03)。
要点
- 极短宫颈(≤10 mm)且无早产史的单胎妊娠,宫颈环扎术与至分娩时间间隔延长相关。
- 环扎术与校正后早产风险降低相关(aHR 0.61,95%CI 0.38–0.99)。
- 已使用阴道孕酮者中,环扎术仍与至分娩时间间隔延长相关(17.0 vs 13.1周,P=.01)。
核心结论
- 对于无症状、宫颈长度≤10 mm且无自发性早产史的单胎妊娠患者,应考虑行宫颈环扎术。
研究设计与样本
- 排除既往自发性早产、早产症状、宫颈扩张>1 cm、使用子宫托、主要胎儿结构畸形或数据缺失者。
- 比较环扎组(52例,57.8%)与非环扎组(38例,42.2%)从诊断至分娩的时间间隔,并做孕酮亚组分析。
主要发现
- 环扎组诊断时孕周更早(21.0 vs 22.0周,P≤.001)且宫颈更短(5 vs 7 mm,P=.002)。
- 环扎组至分娩时间间隔更长(17.0 vs 15.0周,P=.02),校正后早产风险更低(aHR 0.61,95%CI 0.38–0.99,P=.04)。
- 已用孕酮者中,环扎组至分娩时间间隔更长(17.0 vs 13.1周,P=.01),校正后早产风险更低(aHR 0.49,95%CI 0.27–0.87,P=.02)。
- 环扎组晚期早产发生率低于非环扎组(11.5% vs 31.6%,P=.03)。
关键数值与推荐
- 宫颈环扎术推荐用于无症状、宫颈长度≤10 mm且无自发性早产史的单胎妊娠患者。
临床怎么用
- 对妊娠16–23周、宫颈长度≤10 mm且无自发性早产史的无症状单胎妊娠患者,可考虑行宫颈环扎术以延长孕周。
- 即使患者已在接受阴道孕酮治疗,仍可考虑联合宫颈环扎术。
局限性
- 回顾性队列设计,可能存在选择偏倚。
- 环扎组诊断时孕周更早且宫颈更短,基线特征存在差异。
- 样本量较小(共90例),需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data regarding the efficacy of a cervical cerclage for preterm birth prevention in patients with a short cervix and no history of spontaneous preterm birth are limited and inconclusive. OBJECTIVE: This study aimed to determine whether cervical cerclage is associated with an increased time interval to delivery in asymptomatic patients with singleton pregnancies with an extremely short cervical length (≤10 mm) and no history of spontaneous preterm birth. STUDY DESIGN: This was a multicenter retrospective cohort study of asymptomatic patients with singleton pregnancies with a cervical length of ≤10 mm between 16 and 23 weeks' gestation from January 2014 to December 2019. Patients with previous spontaneous preterm birth, symptoms of preterm labor, cervical dilation of >1 cm, pessary, major fetal structural malformations, or missing data were excluded from the study. The primary outcome of time interval from diagnosis to delivery was compared between those who had a cervical cerclage after diagnosis and those who did not. The secondary outcomes included gestational age at delivery and adverse neonatal outcomes. Moreover, a subgroup analysis of all outcomes in patients already being treated with vaginal progesterone in each group was performed. Statistical analysis included chi-square and Wilcoxon rank-sum tests and a multivariate Cox proportional hazard regression for time interval to delivery. RESULTS: Of the 90 patients included in the study, 52 (57.8%) had cervical cerclage, of which 35 (67.3%) were already being treated with progesterone. Moreover, 38 patients (42.2%) did not have cervical cerclage, of which 21 (55.3%) were already being treated with progesterone. Patients in the cervical cerclage group had an earlier gestational age (21.0 vs 22.0 weeks' gestation; P≤.001) and shorter cervical length (5 vs 7 mm; P=.002) at the diagnosis of a short cervix (cervical length≤10 mm) than those who did not have a cerclage. Cervical cerclage was associated with a longer time interval to delivery (17.0 vs 15.0 weeks; P=.02) and lower hazard of earlier delivery after diagnosis (adjusted hazard ratio, 0.61; 95% confidence interval, 0.38-0.99; P=.04) than no cerclage, after accounting for gestational age and cervical length at diagnosis. In patients already treated with progesterone, cervical cerclage was also associated with a longer time interval to delivery (17.0 vs 13.1 weeks; P=.01) and a lower hazard of earlier delivery after diagnosis (adjusted hazard ratio, 0.49; 95% confidence interval, 0.27-0.87; P=.02) compared to those with no cerclage. Late preterm birth was less common in patients with a cervical cerclage compared with those with no cervical cerclage (11.5% vs 31.6%; P=.03). CONCLUSION: Cervical cerclage should be considered in asymptomatic patients with an extremely short cervical length (≤10 mm) and no history of spontaneous preterm birth.
引用
- Gulersen M, Bornstein E, Domney A, et al. Cerclage in singleton gestations with an extremely short cervix (≤10 mm) and no history of spontaneous preterm birth. Am J Obstet Gynecol MFM. 2021. PMID: 34271252. doi:10.1016/j.ajogmf.2021.100430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。